Skip to main content

Table 1 Eag1 expression and clinicopathological characteristics.

From: Ether à go-go potassium channel expression in soft tissue sarcoma patients

  Number of Tumours (%) Eag1 expression (%)
Sex   
   Male 54 (45%) 35 (65%)
   Female 67 (55%) 51 (76%)
Age (years)   
< 14 11 (9%) 9 (82%)
15 – 34 19 (16%) 14 (74%)
35 – 64 65 (54%) 46 (71%)
> 65 26 (21%) 17 (65%)
Histology   
   Fibrosarcoma 12 (10%) 8 (67%)
   Leiomyosarcoma 26 (22%) 19 (73%)
   Liposarcoma 32 (26%) 18 (56%)
   Malignant fibrous histiocytoma 22 (18%) 18 (81%)
   Rhabdomyosarcoma 17 (14%) 14 (82%)
   Synovial sarcoma 12 (10%) 9 (75%)
Grade   
   Low 70 (58%) 49 (70%)
   Moderate 23 (19%) 15 (65%)
   High 28 (23%) 21 (75%)
Size   
   < 5 cm 74 (61%) 52 (70%)
   > 5 cm 47 (39%) 33 (70%)
Site   
   Primary 76 (63%) 57 (75%)
   Recurrence 32 (26%) 18 (56%)
   Metastasis 13 (11%) 11 (85%)
Total 121 86 (71%)